Changing Of The Guard At Merck KGaA With Garijo Succeeding Oschmann As CEO
Ensures Smooth Leadership Transition
Executive Summary
The appointment of Belén Garijo as CEO of the German major from May next year is a small but significant step on the road to addressing gender inequality at the very top level of management in the world of big pharma.
You may also be interested in...
J.P. Morgan Day 1: Companies Make Deal-Making, COVID-19 Promises
Daily round-up from the virtual J.P. Morgan Healthcare Conference: Business development is key topic for Amgen and Vertex; BioNTech talks COVID-19 vaccine supply while Merck KGAA's new CEO pledges to rise to meet the challenges posed by COVID-19.
J.P. Morgan Day 1: Companies Make Deal-Making, COVID-19 Promises
Daily round-up from the virtual J.P. Morgan Healthcare Conference: Business development is key topic for Amgen and Vertex; BioNTech talks COVID-19 vaccine supply while Merck KGAA's new CEO pledges to rise to meet the challenges posed by COVID-19.
Merck KGaA Plays Key Supporting Role For Coronavirus Vaccines
The German drugmaker is seeing growing demand for its services from peers in the pharma world that are looking to develop vaccines to tackle the COVID-19 pandemic.